These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14274828)

  • 1. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.
    KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE
    Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT.
    YUE TF; GUTMAN AB
    Am J Med; 1964 Dec; 37():885-98. PubMed ID: 14246090
    [No Abstract]   [Full Text] [Related]  

  • 3. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.
    HALL AP; HOLLOWAY VP; SCOTT JT
    Ann Rheum Dis; 1964 Nov; 23(6):439-46. PubMed ID: 14229577
    [No Abstract]   [Full Text] [Related]  

  • 4. [TREATMENT OF GOUTY DYSPURINIA BY PARAMETABOLITES AND, ESPECIALLY, BY A XANTHINE OXIDASE INHIBITOR].
    DELBARRE F; AUSCHER C; LABROUSSE C; GERYA DE
    Presse Med (1893); 1965 May; 73():1275-9. PubMed ID: 14273211
    [No Abstract]   [Full Text] [Related]  

  • 5. THE RENAL EXCRETION OF OXYPURINES.
    GOLDFINGER S; KLINENBERG JR; SEEGMILLER JE
    J Clin Invest; 1965 Apr; 44(4):623-8. PubMed ID: 14278178
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL
    Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F; Saporta L; de Géry A; Jabre E
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract]   [Full Text] [Related]  

  • 8. PREVENTION OF HYPERURICEMIA IN LEUKEMIA AND LYMPHOMA: USE OF ALOPURINOL, A XANTHINE OXIDASE INHIBITOR.
    KRAKOFF IH; MEYER RL
    JAMA; 1965 Jul; 193():1-6. PubMed ID: 14297704
    [No Abstract]   [Full Text] [Related]  

  • 9. A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
    Watts RW; Snedden W; Parker RA
    Clin Sci; 1971 Aug; 41(2):153-8. PubMed ID: 5564305
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA; Krömer H; Scott JT; Watts RW
    Clin Sci; 1968 Oct; 35(2):353-62. PubMed ID: 5721238
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of allopurinol, a xanthine oxidase inhibitor, and sulfinpyrazone upon the urinary and serum urate concentrations in eight patients with tophaceous gout.
    Goldfarb E; Smyth CJ
    Arthritis Rheum; 1966 Jun; 9(3):414-23. PubMed ID: 5938056
    [No Abstract]   [Full Text] [Related]  

  • 12. [OUR EXPERIENCES WITH THE TREATMENT OF GOUT].
    GASPARDY G; SCHULHOF O; VIDA M
    Orv Hetil; 1964 Apr; 105():791-5. PubMed ID: 14144985
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesinurad: A Review in Hyperuricaemia of Gout.
    Deeks ED
    Drugs Aging; 2017 May; 34(5):401-410. PubMed ID: 28425024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gout: an overview of available urate lowering therapies].
    Richette P
    Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEW PROSPECTS IN THE TREATMENT OF GOUTY DYSPURINIA.
    DELBARRE F
    Arch Interam Rheumatol; 1964 Jun; 7():230-53. PubMed ID: 14209280
    [No Abstract]   [Full Text] [Related]  

  • 18. Allopurinol in treatment of gout.
    Scott JT; Hall AP; Grahame R
    Br Med J; 1966 Aug; 2(5509):321-7. PubMed ID: 5920652
    [No Abstract]   [Full Text] [Related]  

  • 19. [When and how to prescribe uricosuric agents? The need for urinary alkalinization].
    Lagrue G
    Sem Hop Ther; 1974; 50(7-8):449-52. PubMed ID: 4445888
    [No Abstract]   [Full Text] [Related]  

  • 20. Allopurinol in the treatment of uraemic patients with gout.
    Wilson JD; Simmonds HA; North JD
    Ann Rheum Dis; 1967 Mar; 26(2):136-42. PubMed ID: 6023695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.